🚨Gene-Specific Detection Rate of Adenomas and Advanced Adenomas (AA) in #Lynchsyndrome.➡️Carriers of MLH1/MSH2 pathogenic variants are.at a higher risk of developing AA.➡️AA is a risk factor for developing CRC.@aegastro @gasclinicbcn @hospitalclinic

In a new study, YSM researchers at @YaleCancer say #genetic testing for #LynchSyndrome is a cost-effective option for people living with #colorectal #cancer and their families:

Our #LynchSyndrome event gets underway soon! . Lovely to see @macmillancancer Notts, @LynchSyndromeUK the NHS Bowel Cancer Screening Programme, @MaggiesCentres and @nuhresearch with information stands. #LSNotts

1/Welcome to #CGAIGCJS Tweetorial on “Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6/PMS2-Associated #LynchSyndrome” by CGA-IGC communications committee member @DanLiMD .Full article in @AmJGastro at DOI: 10.14309/ajg.0000000000003369

Dr. Violaine Randrian, a visiting investigator at MSK, spoke about a study that evaluated gene-specific outcomes in individuals with #lynchsyndrome treated with immune checkpoint blockade for advanced #cancer at #ASCO25.

Learn more about this important initiative at 👉 or contact us by email: m.d.valentin@mn.uio.no. #LynchSyndrome #CancerResearch #PLSD #CollaborateForChange.

🧬 #HereditaryCancer Awareness Week: Genetic Mutations 💙. DYK genetic mutations can increase your risk of cancers like #ovariancancer? #BRCA1/2 mutations & conditions like #LynchSyndrome raise the risk for ovarian, breast, colorectal, & uterine cancers. #NoWomanLeftBehind

📢If you missed today’s 2025 CGA-IGC Research Committee webinar "Transforming Cancer Prevention for #LynchSyndrome: Insights and Innovations, the full webinar is now available on demand here 👉 ➡️@AjayBansal_KUMC, University of Kansas Health System, and

Tobacco use is a known cancer risk factor, being especially critical for people with Lynch syndrome. Quitting smoking can be a powerful step towards reducing this risk #TobaccoAwarenessDay2025 #LynchSyndrome .Read more

❌ MYTH: #Lynchsyndrome only increases colorectal cancer risk so you only need to get a genetic test if you have colorectal cancer. ✅ FACT: Lynch syndrome elevates risk for endometrial, ovarian and other cancers too! As Dr. @BjerreTrent explains, genetic testing is.

Amazing patient oriented session showing us the other side of high risk colorectal cancer diagnosis and #LynchSyndrome @CGAIGC #CGAIGC23

Submit your abstracts now! #Insight2026 Deadline 7th September #LynchSyndrome #Polyposis #EOCRC @LValleResearch @kevinjmonahan @dan_buchanan @frankbalaguer @NicolineHoogerb @CGAIGC @EHTG_Tweets.

On behalf of InSiGHT, we are delighted to welcome you to the #InSiGHT2026 meeting in Singapore, taking place from 4 – 7 March 2026 #LynchSyndrome #Polyposis.@insightmeeting .@StMarksGenomics .

What are screening guidelines for patients with #LynchSyndrome at risk for #Genitourinary cancers? . 🟡 Urinary Tract Cancer .If male, MSH2/EPCAM, fam hx GU canc:.👉Consider annual urinalysis starting Age 30-35 . 🔵 Prostate Cancer .If male, MLH1/MSH2/MSH6.👉Consider annual PSA

🧬Today is #LynchSyndromeAwarenessDay - the genetic condition puts people at much higher risk of cancer. Our researchers have worked with services within the NHS to set up the UK’s first comprehensive database of #LynchSyndrome patients, housing clinical and genetic data. 👇

New research from @GeorgeGoshuaMD & Dr. Xavier Llor highlights the importance of early testing for #LynchSyndrome using optimized testing models to prevent and detect cancers earlier. @AGA_CGH @SmilowCancer @YaleGICancers

". our results do not support any tumor triage method. we recommend #universal #germlinetesting for all newly diagnosed #patients w/ #CRC. " Abu-Ghazaleh et al. Studies performing #universal #germlinetesting on all #patients w/ #CRC found 5.1% prevalence of #Lynchsyndrome

Are you going to @FoGenomics this month?. Join our consultant cancer geneticist, Adam Shaw, on the Pyramid stage on Jan 24th at 3:10. He's talking about the importance of screening for #LynchSyndrome, a common genetic condition that increases our risk of developing cancers.

Our first panel focuses on #LynchSyndrome, with experts from CAS Genomics discussing our approach to increasing patient testing rates